Patent · US Active

Irreversible electroporation using nanoparticles

US8465484B2 · kind B2 · utility

112Cited by
111References
28Claims
0Family size

Assignee

Inventors

Key dates

Filing dateOct 30, 2009
Grant dateJun 18, 2013
Priority date
Expiry dateMar 2, 2031

Classification

  • Technology area (CPC A)Human Necessities
  • CPC primaryA61N1/05
  • WIPO fieldMedical technology
  • WIPO sectorInstruments

Abstract

The present invention provides methods, devices, and systems for in vivo treatment of cell proliferative disorders. The invention can be used to treat solid tumors, such as brain tumors. The methods rely on non-thermal irreversible electroporation (IRE) to cause cell death in treated tumors. In embodiments, the methods comprise the use of high aspect ratio nanoparticles with or without modified surface chemistry.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.